Diagnostics for Emerging Infectious Disease Threats Volume II: Viral Disease

Dec 1, 2003
100 Pages - Pub ID: KLI895748
Abstract Table of Contents Search Inside Report Buy By the Section Related Reports

CHAPTER ONE: EXECUTIVE SUMMARY
  • Introduction
  • Scope and Methodology
  • Summary of Major Findings

CHAPTER TWO: EMERGING VIRAL INFECTIONS

  • West Nile Virus
  • Severe Acute Respiratory Syndrome (SARS)
  • Hantaviruses
  • Viral Hemorrhagic Fevers
    • Ebola Virus
    • Marburg Virus
    • Crimean Congo (CCHF)
    • Lassa Fever
    • Yellow Fever

  • Japanese Encephalitis (JE)
  • West Nile Virus (WNV)
  • Dengue (Group B Arbovirus)

CHAPTER THREE: THE MARKETS & TECHNOLOGIES

  • West Nile Virus
    • U.S. West Nile Virus Testing
    • Canada WNV Testing
    • Mexico WNV Testing

  • HantaVirus
    • Human Hantaviral Testing
    • Rodent Hantavirus Testing

  • Dengue
  • SARS
  • Japanese Encephalitis

CHAPTER FOUR: CONCLUSIONS AND STRATEGIC IMPLICATIONS

  • First Conclusion
  • Second Conclusion
  • Third Conclusion
  • Fourth Conclusion
  • Fifth Conclusion
  • Sixth Conclusion

CHAPTER FIVE: COMPANY PROFILES

  • Abbott Laboratories
  • AccuDX
  • Arup Laboratories
  • Bio Merieux
  • Chiron
  • Cypress Diagnostics
  • Eragen Biosciences, Inc.
  • Focus Technologies, Inc.
  • GeneLabs Diagnostics Pte. Ltd.
  • Gen-Probe
  • Hennessy Research Associates
  • InBIOS International
  • LabCorp
  • Medical Analysis Systems, Inc.
  • MCC Medical and Clinical Consortium
  • Mikrogen
  • Ortho-Clinical Diagnostics/Johnson & Johnson
  • PANBIO
  • PROGEN
  • Quest Diagnostics
  • Roche/Roche Molecular Diagnostics
  • Specialty Labs
  • V.I. Technologies, Inc.

APPENDIX: COMPANY DIRECTORY
List of Exhibits

  • Table 2-1: Number of SARS Cases & Deaths
  • Table 2-2: Estimated number of Hanta Pulmonary Syndrome Cases in American Countries in 2003
  • Table 2-3: Number of Ebola Cases by Country 1976-2003
  • Table 2-4: Number of Suspect Yellow Fever Cases by Year and Country
  • Table 2-5: Number of U.S. Human WNV Cases & Deaths
  • Table 2-6: Number of Dengue Cases in the Americas by Region and Year
  • Table 2-7: Number of Dengue Hemorrhagic Fever (DHF) Cases in the Americas by Region and Year
  • Table 2-8: Number of Dengue Hemorrhagic Fever (DHF) Cases in Asia
  • Table 2-9: Number of DHF Cases in Americas by Country 1981-2002
  • Table 2-10: Dengue/DHF Outbreak Cases
  • Table 3-1: Top Emerging Viral Infectious Disease Testing Revenue by Disease 2001-2008
  • Table 3-2: Top Emerging Viral Infectious Disease Testing Volume by Disease 2001-2008
  • Table 3-3: World West Nile Virus Testing Revenue by Region 2001-2008
  • Table 3-4: World West Nile Virus Testing Volume by Region 2001-2008
  • Table 3-5: U.S. West Nile Virus Testing Revenue by Segment 2001-2008
  • Table 3-6: U.S. West Nile Virus Testing Volume by Category 2001-2008
  • Table 3-7: U.S. Commercial West Nile Virus Testing* Revenue 2001-2008
  • Table 3-8: U.S. Commercial West Nile Virus Testing* Volume 2001-2008
  • Table 3-9: U.S. West Nile Virus Commercial Testing Market Share by Competitor 2002 and 2003
  • Table 3-10: U.S. Human West Nile Virus Commercial Testing Volume by Competitor 2002 and 2003
  • Table 3-11: U.S. Public Health West Nile Virus Testing Revenue by Species 2001-2008
  • Table 3-12: U.S. Public Health West Nile Virus Testing Volume by Species 2001-2008
  • Table 3-13: West Nile Virus Human Testing Volume by State 2001-2003
  • Table 3-14: West Nile Virus Human Testing Revenue by State 2001-2003
  • Table 3-15: U.S. West Nile Virus Avian Testing Volume by State, 2001-2003
  • Table 3-16: U.S. WNV Avian Testing Revenue by State 2001-2003
  • Table 3-17: U.S. WNV Mosquito Testing Volume by State 2001-1003
  • Table 3-18: U.S. WNV Mosquito Testing Revenue by State 2001-2003
  • Table 3-19: U.S West Nile Virus Chicken Testing Volume by State, 2001-2003
  • Table 3-20: WNV Chicken Testing Revenue by State 2001-2003
  • Table 3-21: U.S West Nile Virus Equine Testing Volume by State, 2001-2003
  • Table 3-22: WNV Equine Testing Revenue
  • Table 3-23: Health Canada WNV Testing Revenue by Species 2001-2008
  • Table 3-24: Health Canada WNV Testing Volume by Species 2001-2008
  • Table 3-25: Mexican Ministry of Health WNV Testing Revenue by Species 2001-2008
  • Table 3-26: Mexican Ministry of Health WNV Testing Volume by Species 2001-2008
  • Table 3-27: Hantavirus Testing Revenue by Region 2001-2008
  • Table 3-28: HantaVirus Testing Volume by Region 2001-2008
  • Table 3-29: Dengue Test Manufacturers
  • Table 3-30: Sample of Dengue Test List Prices
  • Table 3-31: Taiwan SARS Testing Volume by Technology 2002-2003
  • Table 3-32: SARS Tests for Sale and in Development by Manufacturer

800.298.5603
Int'l: +1.240.747.3096
Questions?
Contact a research specialist >

Most Popular Research
The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 6th Edition [with 2009 economy preface]
The World Market for Molecular Diagnostics
The Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles)
2009 Worldwide Diagnostics Market Research Bundle
In Vitro Diagnostics in a Recessionary Economy: IVD Market Forecasts, Analysis and Success Strategies
Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads
Privacy Policy    |    Terms and Conditions    |    Site Map    |    Return Policy    |    Press    |    Help FAQs
Copyright © 2010 Kalorama Information. All Rights Reserved.
A division of Market Research Group, LLC
Trust-e Logo
Contact Us: 800.298.5603 (U.S.)
or +1.240.747.3096 (Int'l)
Hours: Monday - Thursday: 3:00am - 7:00pm EST
Fridays: 3:00am - 6:00pm EST